Fertility Preservation and
Breast Cancer:
Your Future & Options

Understand how breast cancer treatment affects fertility, what
preservation options exist before and after therapy, and how to
plan for your future family with expert guidance.

Fertility Preservation and Breast Cancer (2)

Welcome

Hearing the words “you have breast cancer”—especially at a younger age—can make everything else feel uncertain. Your plans, your sense of timing, and your hopes for the future may suddenly blur. In the urgency to begin treatment, fertility is often mentioned briefly or not discussed at all, even though many breast cancer treatments can affect fertility and the ability to have biological children later in life.

At Learn Look Locate, we understand that fertility preservation and breast cancer care together can feel complicated, time‑sensitive, and overwhelming. This page is designed to walk you through fertility preservation step by step, using clear language and gentle guidance—so you are not left trying to piece things together on your own.

This content is guided by Learn Look Locate medical advisors Deborah E. Ikhena‑Abel, MD, MSCI, a double board‑certified reproductive endocrinologist and infertility specialist, and Lalymar “Laly” Havern, PharmD, MS, BCACP, a board‑certified ambulatory care pharmacist with deep expertise in oncology and specialty pharmacy. Their combined perspectives help ensure that what you read here is medically accurate, practical, and grounded in real‑world patient experience and medication access.

You are not behind. You are not asking too much. And you are allowed to think about your future—even now.

Why Fertility Matters With Breast Cancer Treatment

Breast cancer treatments can affect fertility because they are designed to target rapidly changing cells or alter hormone levels in the body. While this is essential for treating breast cancer, it can also affect the ovaries, eggs, sperm, or the hormonal environment needed for pregnancy and future fertility; these changes may be temporary or permanent and are not always easy to recognize right away.

Because fertility changes can happen quietly during breast cancer treatment, understanding them becomes especially important. Periods may stop and later return, or the body may feel physically recovered, even though fertility has shifted beneath the surface, and learning what to expect from your specific treatment plan helps reduce uncertainty and gives you language to ask meaningful questions about fertility preservation.

Timing matters, too. Some fertility preservation options may have a limited chance of success if implemented after starting treatment, such as egg or embryo freezing or sperm banking, and learning about fertility early helps keep options open later.

Studies in young women with early-stage breast cancer suggest that commonly used fertility preservation approaches—such as ovarian stimulation with egg or embryo freezing before treatment—have not been shown to worsen short-term breast cancer outcomes, which can be reassuring when patients are weighing their options (Fertility Preservation in Young Women with Early-Stage Breast Cancer).

What Is Oncofertility?

Oncofertility is a part of cancer care that focuses specifically on fertility, bringing together oncology and reproductive medicine to help people understand how cancer treatment may affect their ability to have children and what options may be available to protect that ability.

In practice, oncofertility means explaining fertility risks in clear, compassionate language and supporting timely options such as egg, embryo, ovarian tissue, or sperm preservation before treatment begins, when more such choices may be available, and continuing afterward to help people understand their current fertility, explore pregnancy when it is safe, or consider other family-building paths.

At its heart, oncofertility recognizes that treating cancer and protecting future possibilities can—and should—be part of the same conversation, so fertility preservation and breast cancer treatment belong together in your care.

How Breast Cancer Treatment Affects Fertility

Breast cancer treatment can affect fertility in different ways. The impact depends on the type of therapy you receive, the specific drugs and doses, your age, and your baseline fertility before treatment begins.

Some treatments can directly damage the ovaries and eggs, leading to a change in hormone levels, trigger early menopause, or affect fertility by delaying when it is safe to try for pregnancy. Understanding how each part of your breast cancer treatment plan may affect fertility can help you decide whether fertility preservation should be considered before treatment starts or early in the process.

Chemotherapy and Fertility

Being diagnosed with breast cancer can be so overwhelming that it can be easy to lose sight of life beyond the upcoming battle. Chemotherapy, however, can change fertility in ways that may impact the chances of getting pregnant after treatment ends; some women may experience chemotherapy‑induced amenorrhea (the absence of a menstrual period), premature menopause, or infertility.

Knowing how cancer and chemotherapy might affect your fertility is an important topic to discuss with your treatment team before starting your journey to recovery. Changes in fertility can be affected by your age, the specific chemotherapy drugs used, and the dosages you receive.

Most premenopausal women will temporarily stop menstruating during or following chemotherapy. Those younger than 35 tend to be less likely to develop treatment‑related menopause, and many will regain ovarian function within a few years of chemotherapy, with some becoming pregnant—even if periods are irregular at first. However, the return of regular menses does not guarantee that fertility has fully returned. This further highlights the importance of fertility preservation discussions.

Women diagnosed at age 40 or older who receive chemotherapy are more likely to remain in menopause after treatment ends. If you are already close to the typical menopause age (around 51 years old), chemotherapy for breast cancer may make it more likely that you will enter menopause and no longer be able to conceive afterward.

Tamoxifen, Hormone Therapy, and Pregnancy

Tamoxifen and other endocrine therapies are commonly used after initial treatment for hormone receptor–positive breast cancer to lower the risk of recurrence, and they affect fertility mainly through timing and pregnancy safety.

Pregnancy is generally not recommended while taking tamoxifen because it can harm a developing baby, and endocrine therapy often lasts 5 to 10 years, which can delay pregnancy into years when natural fertility is already declining and can change menstrual cycles and symptoms, making it harder to interpret what is happening with fertility during therapy.

Because of this, many people explore fertility preservation options such as egg or embryo freezing before starting long‑term hormone therapy, and planning pregnancy later requires careful, individualized conversations with your oncology and fertility teams about if and when it may be safe to pause or complete treatment.

Ovarian Suppression and Ovary Removal

Some treatment plans lower estrogen levels by directly targeting the ovaries. Ovarian suppression medications temporarily turn off the ovaries, usually stopping ovulation and periods during treatment, and ovarian function may or may not return after stopping these medications depending on factors such as age and whether chemotherapy was also given.

Radiation and Fertility in Breast Cancer

Most radiation used in breast cancer treatment is directed at the breast or chest wall and does not directly expose the ovaries, so in these common situations radiation alone is unlikely to affect fertility in the same way chemotherapy or ovarian‑targeted treatments can.

In less common cases where radiation fields extend lower in the body, or when radiation is used in other areas in addition to breast cancer care, fertility risks should be discussed, and if there is any chance that the ovaries or uterus may be exposed, it becomes especially important to talk about fertility preservation before radiation begins.

Fertility Stimulation Medications

For egg and embryo freezing, fertility stimulation medications are used to help multiple eggs mature at the same time, typically given as injections over about 10 to 14 days, followed by an egg retrieval procedure.

The goal is to safely collect as many mature eggs as possible within a limited window before breast cancer treatment begins, and fertility clinics and oncology teams often work closely together to coordinate timing so cancer treatment can still start promptly while doing what is possible to protect future fertility.

How Treatment Affects Fertility in Men
(Including Male Breast Cancer)

Men can also be diagnosed with breast cancer, and many treatments can affect male fertility by changing sperm production, hormone levels, or sexual function, with effects that may be temporary or permanent depending on treatment type, dose, and age.

Chemotherapy can damage the testes and interfere with sperm production, leading to a low sperm count or no sperm in the semen, while hormone‑targeted therapies may alter estrogen or other hormone levels and affect libido, erections, and overall reproductive health, and radiation directed near the pelvis or testicles can also reduce sperm count and quality.

Because fertility changes can begin soon after treatment starts, sperm banking (cryopreservation) before therapy is the most reliable way for men to preserve fertility and is best discussed as early as possible after diagnosis.

Why Age Matters in Fertility Preservation

Age plays a central role in how breast cancer treatment affects fertility. As we get older, the number and quality of eggs naturally decline, and this change becomes a key part of fertility planning with or without cancer.

When chemotherapy, hormone therapy, ovarian suppression, or ovary removal are added, their impact can be greater—especially for people closer to menopause when treatment begins; younger patients often start with more eggs and may be more likely to see periods return after chemotherapy, but a return period does not always mean fertility is fully preserved.

Older premenopausal patients usually begin with fewer eggs, so similar therapies can more quickly lead to infertility or early menopause, and because age, treatment type, and dose all interact, talking about fertility preservation early—ideally right after diagnosis and before treatment starts—helps tailor options like egg, embryo, or sperm freezing to your age, treatment plan, and future goals.

Fertility Preservation Options Before Treatment

When possible, fertility preservation is often easiest and most effective before breast cancer treatment begins or very early in the process; many options can be arranged quickly—often within days to a couple of weeks—and coordinated without significantly delaying cancer treatment.

A reproductive endocrinologist (fertility specialist) can help you understand which options make the most sense for your age, diagnosis, and treatment timeline so that fertility preservation and breast cancer treatment planning happen side by side.

Options for Women and People With Ovaries

Fertility preservation for women and people with ovaries focuses on protecting eggs before they are exposed to treatments that may cause damage.

  • Egg (oocyte) freezing: Hormones are used to stimulate egg growth, eggs are retrieved from the ovaries, and mature eggs are frozen unfertilized for future use; this does not require sperm and can be a good choice if you do not have a partner or do not want to make fertilization decisions now.
  • Embryo freezing: Eggs are retrieved, fertilized with sperm from a partner or donor, and frozen as embryos, and this is one of the most established and widely used fertility preservation methods.
  • Ovarian tissue freezing: A small piece of ovarian tissue is surgically removed and frozen for possible re‑implantation later; this may be considered when there is very little time before treatment begins or in younger patients who have not reached puberty.
  • Medications to help protect the ovaries: In some cases, medications that temporarily suppress ovarian function during chemotherapy may be used as part of a broader fertility preservation plan, though they are not a replacement for egg or embryo freezing.

Options for Men and People With Testes

For men and people with testes, fertility preservation focuses on protecting sperm before chemotherapy or other treatments begin.

  • Sperm banking (cryopreservation): Semen is collected and frozen for future use in IUI or IVF and is the most common and reliable option before treatment.
  • Testicular tissue freezing: In certain situations—such as in children or when a semen sample cannot be provided—a small piece of testicular tissue may be removed and frozen through specialized programs.

Because sperm can be affected quickly once treatment starts, sperm banking is often discussed as soon as possible after diagnosis.

Costs, Insurance Coverage, and Financial Navigation

Fertility preservation is a meaningful investment, and cost can be a major barrier—especially when you are already preparing for cancer treatment—so being honest about numbers can help you plan, ask for support, and explore programs that may lower out‑of‑pocket costs.
In the United States, typical ballpark ranges (which can vary by clinic and region) include:

Egg or embryo freezing

  1. One cycle of egg freezing often ranges from about $10,000–$20,000 when medications and monitoring are included.
  2. Many patients need more than one cycle, so total costs can rise significantly.
  3. Ongoing storage fees commonly range from about $500–$1,000 per year for eggs or embryos.

Sperm banking

  1. Initial collection, analysis, and freezing often totals around $500–$1,000.
  2. Storage typically costs about $150–$500 per year, depending on the facility and plan.

Coverage for these services is highly variable. Some insurance plans now recognize fertility preservation as medically necessary when infertility risk comes from cancer treatment, while others still treat it as elective.

It can help to:

  • Ask your fertility clinic for a clear cost breakdown (consults, labs, procedures, medications, storage).
  • Call your insurance company and specifically ask about coverage for fertility preservation related to cancer treatment.
  • Explore financial assistance programs, grants, and manufacturer programs that may provide discounted or no‑cost fertility medications or help with procedure costs.

Specialty pharmacies, including Walgreens Specialty Pharmacy, often play a key role by coordinating quickly with your oncologist and fertility clinic, handling prior authorizations, arranging shipment, and connecting you with programs like Ferring’s Heartbeat Program, which may provide select fertility medications at no cost for eligible patients preserving fertility before cancer treatment.

Support Resources and Medication Access

Navigating fertility preservation alongside a breast cancer diagnosis can feel like a lot to hold. Support can come from your oncology team, reproductive endocrinologist, pharmacists, financial counselors, social workers, and patient navigators who understand both cancer care and fertility.

These professionals can help you understand options, manage timing, and work through logistics, while also connecting you with programs that reduce cost and speed up access to fertility treatment and medications when time matters most.

Medication Access When Timing Is Critical

Medication access is often one of the most urgent parts of fertility preservation. Fertility medications may need to be started quickly and carefully coordinated with your cancer treatment plan, and specialty pharmacies can work directly with your oncologist and fertility clinic to process prescriptions, manage prior authorizations, arrange rapid delivery, and help identify assistance programs and discounts when cost or timing feels like a barrier.

Emotional and Peer Support

Support is not only medical. Emotional and peer support can be just as important when navigating fertility decisions, and programs like Imerman Angels offer one‑on‑one mentor support, connecting you with another survivor who has faced similar questions about fertility and breast cancer.

You may also find it helpful to explore reputable organizations focused on oncofertility, coverage, and financial advocacy, such as the Oncofertility Consortium, SaveMyFertility, the Alliance for Fertility Preservation, and Fertility Within Reach, which help clarify options, insurance challenges, and available support.

Life After Treatment: Pregnancy, Infertility, and Family‑Building

When active treatment ends, questions about fertility and family‑building often come to the surface. You may wonder whether pregnancy is possible, whether it is safe, or what options remain if fertility has changed, and it is normal to feel hope, fear, relief, and grief all at once.

Some people can conceive naturally after breast cancer treatment depending on age, treatment history, and recovery, while others need support from a fertility specialist to understand options such as using frozen eggs or embryos, IVF, donor eggs or sperm, or intracytoplasmic sperm injection (ICSI) to help fertilization; if carrying a pregnancy is not possible or not recommended, family‑building can still include surrogacy, fostering, adoption, or choosing to live child‑free in a way that honors your health and your life.

Alternative Paths to Building a Family: Surrogacy, Adoption, and Embryo Donation

If pregnancy is not possible, not recommended, or not the path you want to pursue, it may help to understand the other ways family‑building can still happen after breast cancer. These paths can look different medically, emotionally, legally, and financially, but they are all real and meaningful ways to create a family.

Surrogacy may be an option for people who cannot safely carry a pregnancy after breast cancer treatment, or who are advised not to become pregnant because of their medical history. In gestational surrogacy, an embryo created through IVF is transferred to a person who carries the pregnancy. That embryo may be created using your own egg or embryo, a partner’s sperm, donor egg or sperm, or a combination of these.

Because surrogacy can involve medical screening, legal agreements, financial planning, and state‑specific regulations, it is often helpful to speak with a reproductive endocrinologist and an attorney who focuses on reproductive law early in the process. If this is something you may want to consider, your oncology and fertility teams can help you understand whether using your own eggs or embryos is still possible and what steps would come next.

Adoption is another meaningful path to parenthood after breast cancer. Some people feel drawn to adoption because pregnancy is no longer possible, while others choose it because it feels like the best fit emotionally, medically, or practically.

The adoption process can vary widely depending on whether you pursue domestic adoption, international adoption, private adoption, or foster‑to‑adopt. Requirements, timelines, costs, and health documentation differ by agency and program, so it can be helpful to ask early how a history of cancer treatment may be reviewed during the application process.

Embryo donation may be an option for people who cannot use their own eggs or embryos, or for those who want to pursue pregnancy without going through egg retrieval. In this process, embryos created by another individual or family and donated for reproductive use are transferred through IVF.

For some, embryo donation offers a path to pregnancy and birth even when ovarian reserve has changed significantly after treatment. This choice can also raise emotional and ethical questions about genetics, disclosure, and future family conversations, so counseling and thoughtful medical guidance can be especially valuable.

This can be an emotionally tender space. Before my breast cancer diagnosis, I went through three rounds of IVF in my early thirties, and I know how demanding and vulnerable this process can feel. That understanding is woven into the care behind this page.

There is no one right way to build a family after breast cancer. For some people, the next step will involve IVF with frozen eggs or embryos. For others, it may be donor eggs, donor sperm, embryo donation, surrogacy, adoption, fostering, or choosing to live child‑free. A reproductive endocrinologist, working with your oncology team, can help you understand what is safe and possible, so you can make decisions that honor both your health and your future.

Emotional Healing, Identity, and Self-Worth

Fertility after breast cancer is not just a medical topic—it can touch your sense of identity, relationships, and future. You may be grieving the family you once pictured, feeling angry about decisions made quickly, or wondering whether others truly understand what you have been through.

Many people quietly ask themselves whether they are still whole if their fertility has changed, but your worth has never been tied to your fertility, your ability to carry a pregnancy, or your relationship status. Hearing words from other survivors, such as Mindy’s reminder that “you are not broken, and you never were,” can be grounding and deeply reassuring, and working with a therapist, social worker, fertility counselor, or peer mentor who understands cancer can help you process grief and rebuild a sense of self.

Hope and Healing Through Breast Cancer

Beyond medical facts, it can help to hear from someone who’s lived this. Mindy’s words offer hope and healing for anyone facing fertility and breast cancer.

Letters from

MINDY

“No matter what your ovarian function or reproductive abilities, please believe me when I tell you that you are not broken, and you never were. You and your body have been through so much, and you are still overcoming the challenges before you. You are beautiful in every way and your fertility will never be a measure of the space you keep and the woman you are. A woman’s worth cannot be measured by her reproductive abilities.”
-Mindy, Stage 2- Emotional Contributor
IG : @msmindymiller

Read Mindy’s letters for a real, honest look at fertility, healing, and life after a young breast cancer diagnosis.

Fertility Preservation and Breast Cancer: What Young Patients Need to Know Before Treatment

For many young women diagnosed with breast cancer, one of the first questions that arises is: Will cancer treatment affect my ability to have children in the future?

In this important discussion, Cynthia Jordan, Founder of Learn Look Locate, speaks with Laly Havern, PharmD, MS, BCACP, Walgreens pharmacist and Learn Look Locate Medical Advisor, and Deborah E. Ikhena-Abel, MD, MSCI, reproductive endocrinologist specializing in onco-fertility, about fertility preservation options for breast cancer patients before treatment begins.

Breast cancer treatments such as chemotherapy, hormone therapy, and radiation can sometimes impact fertility. Understanding the options available before treatment starts can help patients make informed decisions about their future family planning.

In this video, they explain:

  • How breast cancer treatments can affect fertility

  • The critical two-week window for fertility preservation

  • What happens during egg freezing and embryo freezing cycles

  • Possible side effects and emotional considerations

  • Financial assistance programs that may help, including Chick Mission, LIVESTRONG Heartbeat, and ReUnite Onco

If you are a young breast cancer patient or supporting someone who is navigating treatment decisions, this conversation provides clear guidance to help you understand fertility preservation, ask informed questions, and advocate for your future before cancer treatment begins.

Watch the full discussion to learn about fertility options for breast cancer patients.

About the Experts

Deborah E. Ikhena-Abel, MD, MSCI

Deborah E. Ikhena-Abel, MD, MSCI

Learn Look Locate Medical Advisor

Dr. Ikhena-Abel is a double board-certified physician in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. As a Learn Look Locate medical advisor, she helps educate patients and families about fertility preservation options before and after breast cancer treatment.

She works closely with people facing cancer to discuss egg and embryo freezing, understand fertility after treatment, and coordinate with oncology teams so fertility conversations happen early—when more options may still be available. Her guidance helps ensure this page reflects both current medical evidence and the emotional reality of making fertility decisions during cancer care.

Dr. Ikhena-Abel is deeply committed to making complex reproductive medicine feel clear, compassionate, and accessible, so patients feel informed and supported when speaking with their own care teams.

“Breast cancer alone is overwhelming. Infertility alone is overwhelming. When you place those two realities on a patient at the same time, it can feel unimaginable. That’s why conversations about fertility preservation are not optional—they are essential to preserving hope, identity, and a future beyond cancer.  As pharmacists, we stand at a critical point in care where we can bridge gaps that might otherwise be missed—ensuring patients are truly supported, informed, and empowered during one of the most vulnerable moments of their lives.  I’m deeply grateful to Cynthia and Learn Look Locate for creating space for this perspective, because when we elevate these conversations, we don’t just change care—we change outcomes and lives.”

Lalymar Havern, PharmD, MS, BCACP

Learn Look Locate Medical Advisor

Lalymar “Laly” Havern is a board-certified ambulatory care pharmacist with extensive experience in oncology and specialty pharmacy. As a Learn Look Locate medical advisor, she helps educate patients about fertility preservation medications, access, and timing—areas that can feel overwhelming when treatment decisions must happen quickly.

She understands how treatment plans, insurance coverage, prior authorizations, and specialty pharmacy coordination intersect. Her role is to help ensure that conversations about fertility include not just what is medically recommended, but how people can realistically obtain medications and support when time matters.

Laly’s perspective helps bridge the gap between medical recommendations and real-world access, so cost, logistics, and medication delays are less likely to stand between patients and preserving their future options.

Questions to Ask Your Care Team About Fertility

You are allowed to ask direct, detailed questions about fertility—this is part of your breast cancer care, not a distraction from it. You can bring this list (print it, save it in your phone, or screenshot it) to appointments with your oncologist, surgeon, radiation oncologist, and fertility specialist.

  • How could my specific breast cancer treatment plan (chemotherapy, hormone therapy like tamoxifen, ovarian suppression, surgery, radiation) affect my fertility and hormonal health?
  • Based on my age and my current fertility tests, how high is my personal risk of infertility or early menopause from this treatment?
  • Will my periods definitely stop, and if they come back, what will that really tell us about my fertility?
  • Is there time for me to see a reproductive endocrinologist before I start treatment?
  • Which fertility preservation options are realistic for me right now (eggs, embryos, ovarian tissue, sperm banking)?
  • How long would egg or embryo freezing delay my treatment, if at all, and how will you help coordinate that safely?
  • How long will I need to be on tamoxifen or other hormone therapy?
  • Is there a time point in my treatment when it might be safe to talk about pregnancy, if that is something I want?
  • If I stop hormone therapy early to try to get pregnant, what are the risks and how will you help me weigh them?
  • If I do not preserve fertility before treatment, what options might I have afterward to build a family (natural conception, IVF, IVF with ICSI, donor eggs or sperm, surrogacy, adoption)?
  • When treatment is finished or paused, can you refer me to a fertility specialist to evaluate my current fertility and discuss next steps?
  • What will my insurance likely cover when it comes to fertility preservation and fertility treatments related to my breast cancer?
  • Is there someone on the team (navigator, social worker, financial counselor) who can help me understand costs and insurance and connect me to assistance programs?
  • Are there pharmacies or programs you work with that can help me get fertility medications quickly and affordably?

Bringing questions like these to your team does not make you difficult or demanding—it makes you a partner in your own care and honors the life you are planning for after treatment.

Frequently Asked Questions (FAQs) About Oncofertility

Oncofertility is a medical field that bridges oncology and reproductive medicine, focusing on helping individuals with cancer preserve their fertility before treatments that might impact their ability to have children.

Many cancer treatments—such as chemotherapy, radiation, and some surgeries—can damage reproductive organs or disrupt hormone production, which may result in temporary or permanent infertility. Fertility preservation allows patients to consider biological parenthood after surviving cancer.

Options for women include egg (oocyte) freezing, embryo freezing, ovarian tissue freezing, and medications to protect the ovaries during treatment.

The most common method is sperm banking (cryopreservation). For prepubertal boys or those unable to provide a sample, testicular tissue freezing may be considered.

You should address fertility preservation as soon as possible after your cancer diagnosis and before starting any treatment, since some options may only be available prior to therapy.

Most procedures are considered safe; however, risks and success rates vary by age, health status, and chosen method. Consulting a fertility specialist can help you understand your specific situation.

Some fertility preservation procedures, like egg or sperm retrieval, may cause a brief delay—often less than two weeks—but most patients can still begin cancer treatment promptly.

Coverage varies depending on your insurance plan, location, and the specific procedure. Contact your insurer and medical team about coverage and possible financial assistance. There are also grants and manufacturer programs available if you do not have insurance coverage or have lost an appeal.

Yes, there are options such as ovarian or testicular tissue freezing, although some of these methods may still be considered experimental for young patients.

Speak with your oncologist or a fertility specialist or explore reputable resources such as the American Society for Reproductive Medicine (ASRM) or the Oncofertility Consortium.

Explore Fertility and Family Planning Clinical Trials

Learn Look Locate is dedicated to supporting breast cancer patients in all aspects of their lives, including fertility and family planning. Through our partnership with BreastCancerTrials.org, we offer access to clinical trials focused on fertility preservation and having children after breast cancer treatment.

This content has been medically reviewed by:

Lalymar Havern

PharmD, MS, BCACP and Medical Advisor for Learn Look Locate
&

Deborah E. Ikhena-Abel MD

MSCI and Medical Advisor for Learn Look Locate

Average IVF treatment costs:

  • $6,107 for a natural IVF procedure
  • $5,948 for a mild IVF procedure
  • $10,424 for a standard IVF procedure

Average IVF with egg donation treatment costs:

  • $13,108 for an IVF with anonymous egg donation

Average IVF with embryo donation treatment costs:

  • $3,850 for an IVF with anonymous embryo donation

Average IVF with sperm donation treatment costs:

  • $1,669 for an IVF with anonymous sperm donation

It is important to note that these costs are in addition to the costs associated with freezing your embryos or eggs, which averages $7,500.

I personally went through three rounds of IVF in my early thirties, so I have a deep understanding of the emotional rollercoaster that often comes with the fertility journey. I have such compassion and empathy for any woman facing the challenges involved with trying to have a family. I believe it is so important for a woman who is facing a breast cancer diagnosis to be empowered, and this begins by having a better understanding of all her fertility options, being prepared, and knowing more about the impact this can have on planning a family.

Another option to stimulate fertility is using a class of medication called gonadotropins. Common names for this type of drug can include Follistim, Menopur, Bravelle, or Gonal-F. Gonadotropins contain an active form of the FSH, which is the main hormone that is responsible for producing mature eggs in the ovaries and they have been shown to be often capable of inducing ovulation in women who have not had success with Clomid or Letrozole. Another benefit of using gonadotropins is that they can regulate the menstrual cycle, which means that ovulation can be predicted more precisely.

If you are premenopausal and always wanted a child or are unsure but still want the option to choose, then it is important to talk to your doctor about your fertility options before your cancer treatment begins. Your team will help you find a balance between treating your cancer and having the ability to have children. Today, there are several options open to women who want to preserve their fertility when diagnosed with breast cancer, including freezing embryos for IVF, freezing eggs, and freezing ovarian tissues.

Freezing embryos for IVF is the most effective way of preserving fertility. This process involves taking hormones to stimulate your ovaries to make eggs. A doctor then removes the eggs and fertilizes them with the donor’s sperm (if you don’t have a male partner at this stage) to create an embryo which is then frozen and stored. The biggest disadvantage of choosing this process is that it takes time, and this could result in a delay to receiving your cancer treatment.

Freezing eggs is a quicker way to preserve your fertility because it doesn’t require fertilization. You will take hormones to stimulate egg growth and then the doctor will remove the eggs and freeze them. When you are ready to become pregnant, the eggs are thawed and injected with the donor’s sperm to fertilize them. The biggest disadvantage with this process is that the freezing and thawing process can sometimes damage the eggs, resulting in an unsuccessful pregnancy.

Freezing ovarian tissues is a newer fertility option that is still in development. Also called ovarian tissue cryopreservation, this process involves surgically removing ovarian tissue and then freezing it. After the cancer treatment is finished, the tissue is put back.

Fetotoxicity is a process by which the fetus is poisoned by a medication. When this occurs, it can compromise maternal health and result in fetal malformations, altered growth, and even in utero death. As a result, Tamoxifen should only be used during pregnancy when the benefits of the drug clearly and significantly outweigh the risks to the unborn child.

Knowing how cancer might affect your fertility is therefore an important thing to discuss with your treatment team before you start on your journey to recovery. Research shows that changes in fertility can not only be affected by your age, but also by which chemotherapy drugs are being used to treat your cancer and the dosage of the drugs.

While most premenopausal women will usually temporarily stop menstruating during or following chemotherapy, those younger than 35 tend to be less likely to develop treatment-related menopause. Most will regain healthy ovarian function within a few years after chemotherapy and some even get pregnant while not menstruating.

Meanwhile, women who are diagnosed with breast cancer and receive chemotherapy at 40 or older are more likely to remain in menopause after chemotherapy ends. If you are already close to menopause age, typically around 51 years old, and undergo chemo for breast cancer, then most likely you will enter menopause and not be able to conceive after treatment.